drugset

drugset / Trial / NCT00141882

Memantine in Patients With Chronic Glaucoma

NCT00141882 ↗

Phase 3 Completed 1119 enrolled Allergan

RandomizedParallel-groupDouble-blindTreatment

Summary

Randomized double-masked clinical trial of memantine in patients with glaucoma

Timeline

Start: 1999-03
Primary completion: 2006-01
Completion: 2006-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Memantine	Unknown	—	—

Indications